Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -48.36% |
| Q3 2025 | -5.17% |
| Q2 2025 | -17.01% |
| Q1 2025 | -16.23% |
| Q4 2024 | -13.41% |
| Q3 2024 | -6.16% |
| Q2 2024 | -23.13% |
| Q1 2024 | 131.59% |
| Q4 2023 | -11.86% |
| Q3 2023 | -7.24% |
| Q2 2023 | -5.94% |
| Q1 2023 | -47.64% |
| Q4 2022 | -13.42% |
| Q3 2022 | 95.58% |
| Q2 2022 | -12.34% |
| Q1 2022 | -11.35% |
| Q4 2021 | -10.87% |
| Q3 2021 | -6.65% |
| Q2 2021 | -14.29% |
| Q1 2021 | -12.22% |
| Q4 2020 | -12.62% |
| Q3 2020 | -46.47% |
| Q2 2020 | 117.83% |
| Q1 2020 | 7411.53% |
| Q4 2019 | -101.16% |
| Q3 2019 | -16.99% |
| Q2 2019 | -70.44% |
| Q1 2019 | -8.47% |
| Q4 2018 | 1.96% |
| Q3 2018 | 50.39% |
| Q2 2018 | -20.03% |
| Q1 2018 | -17.23% |
| Q4 2017 | -12.18% |
| Q3 2017 | -10.68% |
| Q2 2017 | -10.25% |
| Q1 2017 | -9.17% |
| Q4 2016 | -6.40% |
| Q3 2016 | -8.65% |
| Q2 2016 | -7.92% |
| Q1 2016 | -10.38% |